ARCA biopharma Announces Health Canada Acceptance Of Genetic-AF Clinical Trial Application
August 18, 2014 at 08:32 AM EDT
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, ...